Ripple confirms top Korean banks and RippleX leaders for XRP Seoul 2026 event

Cointurk2026/09/28 08:51

By:Cointurk

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Leading South Korean financial institutions and Ripple executives are set to gather at the XRP Seoul 2026 conference, scheduled for October 3 at the Grand Hyatt Seoul. The official speaker lineup now includes senior leadership from Woori Bank, Kakao Bank, Kyobo Securities, and Kbank, joining Ripple President Monica Long and RippleX Senior Vice President Markus Infanger for a program focused on institutional crypto adoption.

Major Korean banks to address XRPL adoption Expanding Ripple’s institutional footprint in Asia In-depth sessions on tokenization and DeFi

Major Korean banks to address XRPL adoption

Woori Bank will participate through senior manager Seunghoon Han, while Kakao Bank is sending manager Leo Lee. Kyobo Securities, a key player in South Korea’s investment industry, will be represented by Executive Director Heejin Shin. Kbank, one of the country’s leading digital-only banks, is sending digital-asset TF lead Jaehyuk Choi.

These speakers reflect Ripple’s growing institutional partnerships in South Korea, a region that is increasingly looking to blockchain for financial infrastructure modernization.

Among the key themes, institutional adoption of the XRP Ledger (XRPL) will take center stage, with discussions on asset tokenization, cross-border payments, and the future of institutional DeFi in Korea.

Kbank has actively collaborated with Ripple on blockchain solutions for overseas remittances, testing digital-asset platforms for efficient international transfers. Woori Bank and other institutions are also evaluating similar integrations, signaling growing interest in Ripple-powered payment technologies.

Expanding Ripple’s institutional footprint in Asia

South Korea is taking steps toward tokenized government bond settlement, exploring the use of Ripple infrastructure not only for cross-border payments but also for capital market systems. This pivot positions Ripple as a core provider of both payment and tokenization tools within the country’s financial sector.

Ripple is reinforcing its position in institutional tokenization through its Asian stack, notably by integrating solutions such as Ripple Custody and SettleMint. These partnerships grant licensed institutions regulated infrastructure for the issuance, management, and custody of tokenized assets.

Mini dictionary: RippleX, a division of Ripple, focuses on developing XRP Ledger (XRPL) infrastructure and ecosystem tools that support developers and institutions building on the XRP Ledger blockchain.

In-depth sessions on tokenization and DeFi

The conference agenda features a robust slate of panels and presentations intended for institutional audiences. One 30-minute panel will explore the traditional finance sector’s adoption of asset tokenization, followed by a session forecasting the future of tokenized assets. Another discussion is dedicated to institutional decentralized finance (DeFi) developed on XRPL technology.

Additional sessions will cover RLUSD and its role in cross-border payments, institutional XRP management, and projections for both XRP and the broader XRP Ledger ecosystem.

Program highlights include real-world case studies of blockchain-based payments and tokenized asset management, demonstrating Ripple’s expanding role across Asia’s regulated financial sector.

Institutions and regulators in the region are expected to gain first-hand insights into how blockchain solutions can drive modernization and reduce friction in traditional finance operations.

By bringing together Korean banking leaders and core Ripple executives, XRP Seoul 2026 is set to showcase the strides Ripple has made in building a comprehensive ecosystem for institutional blockchain adoption in Asia.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

In October, US non-farm payrolls increased by 165,000, which is 2.5 times the Wall Street median forecast of 65,000 and represents an exceptionally strong deviation of about 5 standard deviations, exceeding the upper limit of all institutional forecast ranges. The unemployment rate unexpectedly fell from 4.2% to 4.1%, while the market had expected it to remain unchanged; average hourly wages also accelerated year-on-year growth to 3.1%. Meanwhile, the previous two months' non-farm payrolls were revised upwards by a total of 84,000. Following the release of the data, the yield on 2-year US Treasury bonds rose by 7 basis points, and the pricing of the probability of a Fed rate hike in December climbed to 70%.

华尔街见闻•2026/11/06 15:01

AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.

华尔街见闻•2026/11/06 13:42

AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

Trump Media Stock (DJT) Plunge Destroys $2.2 Billion in Retail Wealth as Donald Trump Keeps $460 Million Stake

Tipranks•2026/11/06 13:39

Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight

Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.

华尔街见闻•2026/11/06 13:23